Journal article
Octreotide and cholecystokinin antagonist reduce edema in obstruction-induced acute pancreatitis
The Journal of laboratory and clinical medicine, Vol.122(4), pp.450-454
10/1993
PMID: 8228560
Abstract
Obstruction-induced acute pancreatitis in rats is associated with increased plasma cholecystokinin (CCK) levels. Duodenal replacement of bile reduces severity of pancreatitis and limits CCK increase. We investigated the role of CCK in the pathogenesis of obstruction-induced acute pancreatitis by pretreating rats with the somatostatin analog octreotide and the CCK antagonist L-364,718. Octreotide inhibits duodenal CCK release, and L-364,718 competitively blocks CCK receptors. We studied 31 rats after (1) sham operation (n = 7), (2) bile and pancreatic duct obstruction (BPDO) (n = 12), (3) BPDO plus octreotide (20 micrograms/kg IP and then 5 micrograms/kg/hr IV) (n = 6), and (4) BPDO plus L-364,718 (1 mg/kg IP and then 0.25 mg/kg/hr IV) (n = 6). Rats were killed after 18 hours. Pancreas weight, acute pancreatitis histology score, and plasma amylase and CCK levels were determined. Octreotide and L-364,718 limited the increase in pancreas weight. Octreotide also limited the rise in plasma CCK levels. These findings suggest that CCK may play a role in the pathogenesis of obstruction-induced acute pancreatitis.
Details
- Title: Subtitle
- Octreotide and cholecystokinin antagonist reduce edema in obstruction-induced acute pancreatitis
- Creators
- Y Toriumi - Surgical and Research Services, Veterans Affairs Lakeside Medical Center, Chicago, IL 60611I SamuelD P WilcocksonC M TurkelsonT E SolomonR J Joehl
- Resource Type
- Journal article
- Publication Details
- The Journal of laboratory and clinical medicine, Vol.122(4), pp.450-454
- PMID
- 8228560
- NLM abbreviation
- J Lab Clin Med
- ISSN
- 0022-2143
- eISSN
- 1532-6543
- Publisher
- Elsevier; United States
- Language
- English
- Date published
- 10/1993
- Academic Unit
- Surgery
- Record Identifier
- 9984051534602771
Metrics
21 Record Views